View in EDS HTML Full Text PDF Full Text

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia.

Saved in:
Bibliographic Details
Title: Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia.
Authors: Bastian, Moritz B.1 (AUTHOR), Sieben, Maike1 (AUTHOR), Blickle, Arne1 (AUTHOR), Burgard, Caroline1 (AUTHOR), Speicher, Tilman1 (AUTHOR), Bartholomä, Mark1 (AUTHOR), Schaefer-Schuler, Andrea1 (AUTHOR), Maus, Stephan1 (AUTHOR), Ezziddin, Samer1 (AUTHOR), Rosar, Florian1 (AUTHOR) florian.rosar@uks.eu
Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2025, Vol. 52 Issue 4, p1271-1277. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-024-07006-z